Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar-Apr;5(2):170-178.
doi: 10.1016/j.ogla.2021.07.009. Epub 2021 Jul 30.

Macular Thickness and Microvasculature Loss in Glaucoma Suspect Eyes

Affiliations

Macular Thickness and Microvasculature Loss in Glaucoma Suspect Eyes

Huiyuan Hou et al. Ophthalmol Glaucoma. 2022 Mar-Apr.

Abstract

Purpose: To characterize the change of ganglion cell complex (GCC) thickness and macular vessel density in glaucoma suspect eyes with ocular hypertension (OHT) or glaucomatous optic neuropathy (GON).

Design: Prospective, longitudinal study.

Participants: Eight-three eyes (24 healthy, 30 OHT, and 29 GON) of 65 patients who underwent at least 3 visits were included from the Diagnostic Innovations in Glaucoma Study. The mean follow-up was at least 3 years.

Methods: OCT angiography (OCTA)-based vessel density and OCT-based structural thickness of the 3 × 3-mm1 GCC scan slab were evaluated at each visit. The rates of vessel density and thickness change were compared across diagnostic groups using a linear mixed-effects model.

Main outcome measures: Change rates of macula GCC thickness and superficial vessel density.

Results: Significant mean rates of both GCC thinning and vessel density loss were detectable in OHT and GON groups. Of the individual suspect eyes, 49.1% showed significant loss (P < 0.05) with either vessel density or GCC thickness. Of the GON eyes, 31.0% showed both significant GCC loss and vessel density loss, 51.7% showed only significant GCC loss, whereas 17.2% showed only significant vessel density loss. Vessel density loss was faster than GCC thinning in half of the suspect eyes based on percent loss analysis. The age and scan quality-adjusted GCC thinning rates of the OHT group (-0.59 μm/year; P = 0.025) and GON group (-0.79 μm/year; P = 0.058) were faster than those of the healthy group (-0.11 μm/year), whereas the rate of vessel density loss was not significantly different among the diagnostic groups (all P > 0.2). Higher mean intraocular pressure during follow-up was associated with faster GCC thinning in the OHT group (P = 0.065) and GON groups (P = 0.015), but was not associated with the rate of vessel density decrease.

Conclusions: Whereas the rate of GCC thinning was faster on average in suspect eyes than in healthy eyes, some suspect eyes showed significant loss of vessel density and faster vessel density loss than GCC thinning. OCT and OCTA are complementary and useful for evaluating eyes with OHT or GON.

Keywords: Glaucoma; Longitudinal; Macula; OCT; OCT angiography.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Parafoveal sectoral age and QI adjusted rates of ganglion cells complex (GCC) thinning of Healthy, ocular hypertension (OHT), and glaucomatous optic neuropathy (GON) eyes. The hotter color represents the faster thinning. The order from slowest to fastest is: Healthy, TSNI; OHT, INST; GON, ITNS. T, temporal; S, superior; N, nasal; I, inferior. Data are presented as the age and scan quality adjusted GCC thickness thinning rate (μm/year).
Figure 2.
Figure 2.
Parafoveal sectoral age and QI adjusted rates of macular vessel density loss of Healthy, ocular hypertension (OHT), and glaucomatous optic neuropathy (GON) eyes. The hotter color represents the faster loss. The order from slowest to fastest is: Healthy, TISN; OHT, ISNT; GON, ISNT. T, temporal; S, superior; N, nasal; I, inferior. Data are presented as the age and scan quality adjusted vessel density loss rate (%/year).

References

    1. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311(18):1901–11. - PMC - PubMed
    1. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004;363(9422):1711–20. - PubMed
    1. Hood DC. Imaging Glaucoma. Annu Rev Vis Sci 2015;1:51–72. - PubMed
    1. De Moraes CG, Hood DC, Thenappan A, et al. 24–2 Visual Fields Miss Central Defects Shown on 10–2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma. Ophthalmology 2017;124(10):1449–56. - PMC - PubMed
    1. Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol 1990;300(1):5–25. - PubMed

Publication types